Comparison of overall efficacy and safety of oral versus subcutaneous methotrexate in severe psoriasis.

Dogra, Sunil; Singh, Namrata; Kumar, Sheetanshu; Narang, Tarun; Handa, Sanjeev

Dogra, Sunil; Singh, Namrata; Kumar, Sheetanshu; Narang, Tarun; Handa, Sanjeev.

Afiliación

Dogra S; Department of Dermatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Singh N; Department of Dermatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Kumar S; Department of Dermatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Narang T; Department of Dermatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Handa S; Department of Dermatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Dermatol Ther ; 35(8): e15656, 2022 08.

Article en En | MEDLINE | ID: mdl-35730664

Asunto(s)

Metotrexato; Psoriasis; Adulto; Enfermedad Crónica; Humanos; Estudios Prospectivos; Psoriasis/inducido químicamente; Psoriasis/diagnóstico; Psoriasis/tratamiento farmacológico; Índice de Severidad de la Enfermedad; Resultado del Tratamiento

Palabras clave

PASI90; oral versus subcutaneous methotrexatemethotrexate; severe psoriasis; subcutaneous methotrexate

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Psoriasis / Metotrexato Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: Dermatol Ther Asunto de la revista: DERMATOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: India

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google